NeuroMetrix Statistics
Share Statistics
NeuroMetrix has 2.04M shares outstanding. The number of shares has increased by 85.57% in one year.
| Shares Outstanding | 2.04M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.71% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 1.46M |
| Failed to Deliver (FTD) Shares | 50 |
| FTD / Avg. Volume | 0.29% |
Short Selling Information
The latest short interest is 15.78K, so 0.77% of the outstanding shares have been sold short.
| Short Interest | 15.78K |
| Short % of Shares Out | 0.77% |
| Short % of Float | 1.08% |
| Short Ratio (days to cover) | 1.12 |
Valuation Ratios
The PE ratio is -0.57 and the forward PE ratio is 9.2.
| PE Ratio | -0.57 |
| Forward PE | 9.2 |
| PS Ratio | 0.64 |
| Forward PS | null |
| PB Ratio | 0.19 |
| P/FCF Ratio | -0.6 |
| PEG Ratio | n/a |
Enterprise Valuation
NeuroMetrix Inc. has an Enterprise Value (EV) of 2.26M.
| EV / Earnings | -0.35 |
| EV / Sales | 0.38 |
| EV / EBITDA | -0.32 |
| EV / EBIT | -0.32 |
| EV / FCF | -0.36 |
Financial Position
The company has a current ratio of 16.81, with a Debt / Equity ratio of 0.01.
| Current Ratio | 16.81 |
| Quick Ratio | 15.55 |
| Debt / Equity | 0.01 |
| Total Debt / Capitalization | 0.73 |
| Cash Flow / Debt | -41.01 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.32% and return on capital (ROIC) is -35.17%.
| Return on Equity (ROE) | -0.32% |
| Return on Assets (ROA) | -0.3% |
| Return on Capital (ROIC) | -35.17% |
| Revenue Per Employee | 226.98K |
| Profits Per Employee | -251.13K |
| Employee Count | 26 |
| Asset Turnover | 0.28 |
| Inventory Turnover | 1.25 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 7.93% in the last 52 weeks. The beta is 2.3, so NeuroMetrix 's price volatility has been higher than the market average.
| Beta | 2.3 |
| 52-Week Price Change | 7.93% |
| 50-Day Moving Average | 4.08 |
| 200-Day Moving Average | 3.91 |
| Relative Strength Index (RSI) | 43.99 |
| Average Volume (20 Days) | 17.09K |
Income Statement
In the last 12 months, NeuroMetrix had revenue of $5.90M and earned -$6.53M in profits. Earnings per share was $-6.27.
| Revenue | 5.90M |
| Gross Profit | 3.95M |
| Operating Income | -7.15M |
| Net Income | -6.53M |
| EBITDA | -7.10M |
| EBIT | -7.15M |
| Earnings Per Share (EPS) | -6.27 |
Balance Sheet
The company has $1.73M in cash and $240.88K in debt, giving a net cash position of $1.49M.
| Cash & Cash Equivalents | 1.73M |
| Total Debt | 240.88K |
| Net Cash | 1.49M |
| Retained Earnings | -210.11M |
| Total Assets | 17.19M |
| Working Capital | 15.59M |
Cash Flow
In the last 12 months, operating cash flow was -$6.08M and capital expenditures -$183.54K, giving a free cash flow of -$6.27M.
| Operating Cash Flow | -6.08M |
| Capital Expenditures | -183.54K |
| Free Cash Flow | -6.27M |
| FCF Per Share | -6.02 |
Margins
Gross margin is 66.89%, with operating and profit margins of -121.18% and -110.64%.
| Gross Margin | 66.89% |
| Operating Margin | -121.18% |
| Pretax Margin | -110.64% |
| Profit Margin | -110.64% |
| EBITDA Margin | -120.24% |
| EBIT Margin | -121.18% |
| FCF Margin | -106.22% |
Dividends & Yields
NURO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -164.57% |
| FCF Yield | -80.59% |
Analyst Forecast
Currently there are no analyst rating for NURO.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Nov 22, 2023. It was a backward split with a ratio of 1:8.
| Last Split Date | Nov 22, 2023 |
| Split Type | backward |
| Split Ratio | 1:8 |
Scores
| Altman Z-Score | -13.97 |
| Piotroski F-Score | 1 |